Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inbal Goldshtein

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Endocrinology|February 19, 2026
Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry studyVanessa Rouach, Ohad Regev, Hilary Gortler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2021
Bone Mineral Density of the 1/3 Radius Refines Osteoporosis Diagnosis, Correlates With Prevalent Fractures, and Enhances Fracture Risk EstimatesLiana Tripto-Shkolnik, Iris Vered, Naama Peltz-Sinvani, et al.
The American Journal of Cardiology|October 2, 2012
Continuation of statin therapy and primary prevention of nonfatal cardiovascular eventsVarda Shalev, Inbal Goldshtein, Avi Porath, et al.
Frontiers in Endocrinology|May 28, 2026
Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry studyVanessa Rouach, Ohad Regev, Hilary Gortler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 29, 2014
Erratum to: Efficacy of Liraglutide in a Real-Life CohortAnthony Heymann, Yasmin Maor, Inbal Goldshtein, et al.
Bone|November 13, 2019
Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare providerLiana Tripto-Shkolnik, Naama Fund, Vanessa Rouach, et al.
The Journal of Pediatrics|August 26, 2022
Trends and Correlates of Early-Life Exposure to Acid-Suppressant Therapy in Israel (2005-2020)Tomer Achler, Gabriel Chodick, Ron Shaoul, et al.
Archives of Dermatology|April 18, 2012
Ocular adverse effects of systemic treatment with isotretinoinMeira Neudorfer, Inbal Goldshtein, Orna Shamai-Lubovitz, et al.
Archives of Disease in Childhood|September 27, 2023
Association of early-life exposure to acid-suppressive therapy and fractures during childhood: a retrospective cohort studyTomer Achler, Gabriel Chodick, Ron Shaoul, et al.
Archives of Osteoporosis|April 13, 2026
Prevalence of Osteoporosis in Elderly Men: Large Real-World Data Addressing the Current Screening Evidence GapVanessa Rouach, Ziv Versano, Meital Sasson, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Endocrinology|February 19, 2026
Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry studyVanessa Rouach, Ohad Regev, Hilary Gortler, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2021
Bone Mineral Density of the 1/3 Radius Refines Osteoporosis Diagnosis, Correlates With Prevalent Fractures, and Enhances Fracture Risk EstimatesLiana Tripto-Shkolnik, Iris Vered, Naama Peltz-Sinvani, et al.
The American Journal of Cardiology|October 2, 2012
Continuation of statin therapy and primary prevention of nonfatal cardiovascular eventsVarda Shalev, Inbal Goldshtein, Avi Porath, et al.
Frontiers in Endocrinology|May 28, 2026
Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry studyVanessa Rouach, Ohad Regev, Hilary Gortler, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 29, 2014
Erratum to: Efficacy of Liraglutide in a Real-Life CohortAnthony Heymann, Yasmin Maor, Inbal Goldshtein, et al.
Bone|November 13, 2019
Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare providerLiana Tripto-Shkolnik, Naama Fund, Vanessa Rouach, et al.
The Journal of Pediatrics|August 26, 2022
Trends and Correlates of Early-Life Exposure to Acid-Suppressant Therapy in Israel (2005-2020)Tomer Achler, Gabriel Chodick, Ron Shaoul, et al.
Archives of Dermatology|April 18, 2012
Ocular adverse effects of systemic treatment with isotretinoinMeira Neudorfer, Inbal Goldshtein, Orna Shamai-Lubovitz, et al.
Archives of Disease in Childhood|September 27, 2023
Association of early-life exposure to acid-suppressive therapy and fractures during childhood: a retrospective cohort studyTomer Achler, Gabriel Chodick, Ron Shaoul, et al.
Archives of Osteoporosis|April 13, 2026
Prevalence of Osteoporosis in Elderly Men: Large Real-World Data Addressing the Current Screening Evidence GapVanessa Rouach, Ziv Versano, Meital Sasson, et al.
Pageof 7